TPI1 antibody (N-Term)
Quick Overview for TPI1 antibody (N-Term) (ABIN630577)
Target
See all TPI1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- TPI1 antibody was raised against the N terminal of TPI1
-
Purification
- Affinity purified
-
Immunogen
- TPI1 antibody was raised using the N terminal of TPI1 corresponding to a region with amino acids MAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYID
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
TPI1 Blocking Peptide, (ABIN5616740), is also available for use as a blocking control in assays to test for specificity of this TPI1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of TPI1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- TPI1 (Triosephosphate Isomerase 1 (TPI1))
-
Alternative Name
- TPI1
-
Background
- TPI1 belongs to the triosephosphate isomerase family. Defects in TPI1 are the cause of triosephosphate isomerase deficiency (TPI deficiency) . TPI deficiency is an autosomal recessive disorder. It is the most severe clinical disorder of glycolysis. It is associated with neonatal jaundice, chronic hemolytic anemia, progressive neuromuscular dysfunction, cardiomyopathy and increased susceptibility to infection.
-
Molecular Weight
- 27 kDa (MW of target protein)
-
Pathways
- Cell RedoxHomeostasis
Target
-